Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04807712 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pediatric Pertussis in Ambulatory Settings

Study acronym: ACTIVCOQ
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jan 1, 2024 to Jan 1, 2030
    • Study completion date: Jan 1, 2025 to Jan 1, 2030
    v5
  2. Enrollment target: 874 to 898
    • Start date: Jan 1, 2002 to May 30, 2001
    • Interventions: non interventionnal study (Other) to non interventional study (Other)
    • Eligibility criteria revised
    v4
  3. Primary completion date: Jan 1, 2002 to Jan 1, 2024v3
  4. Study Status, Referencesv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Since 2002, Whooping cough surveillance in pediatric private practice has been set up in France. The results of the first years, 2002-2006, have confirmed the effectiveness of the Pertussis whole-cell (Pw) vaccine and in particular the duration of protection of 9/10 years. After evaluating cases in children vaccinated with Pw vaccines, the study aims today to analyze cases in children vaccinated with Pertussis acellular (Pa) vaccines used since 2002/2003 and to assess, on an outpatient basis, the impact of new vaccine recommendations in France (in 2013, introduction of a 2 + 1 schedule - 8 weeks, 4 months and a 11-month recall - and a 6-year recall, and in 2014, update in the recommendations of exams to be prescribed based on the child's age and vaccination status).
Trial Details
NCT Number NCT04807712
Lead Sponsor Association Clinique Thérapeutique Infantile du val de Marne
Collaborators: GlaxoSmithKline, Sanofi, Merck Sharp & Dohme LLC
Conditions
(from sponsor)		 Pertussis/Whooping Cough, Children, Only, Ambulatory
Related terms Whooping Cough
Enrollment 898 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov